Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Camostat Mesilate on COVID-19 Infection
2020-001200-42Phase 2Terminated
- Sponsor
- Aarhus University Hospital
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in coronavirus disease 2019 (COVID-19) comparing Camostat mesilate with Placebo (2 arms). Primary endpoint: Primary endpoint (Cohort 1). Started Mar 2020; status: terminated.
02
Drugs
camostat mesilate
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001200-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001200-42.